Literature DB >> 10083413

Prolongation of ex vivo-perfused pig xenograft survival by the complement inhibitor Compstatin.

A E Fiane1, T E Mollnes, V Videm, T Hovig, K Høgåsen, O J Mellbye, L Spruce, W T Moore, A Sahu, J D Lambris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10083413     DOI： 10.1016/s0041-1345(98)01844-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

2.  A simple, yet highly accurate, QSAR model captures the complement inhibitory activity of compstatin.

Authors:  Chandrika Mulakala; John D Lambris; Yiannis Kaznessis
Journal:  Bioorg Med Chem       Date:  2006-12-13       Impact factor: 3.641

Review 3.  Compstatin: a complement inhibitor on its way to clinical application.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatin.

Authors:  Paola Magotti; Daniel Ricklin; Hongchang Qu; You-Qiang Wu; Yiannis N Kaznessis; John D Lambris
Journal:  J Mol Recognit       Date:  2009 Nov-Dec       Impact factor: 2.137

5.  Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40.

Authors:  Junxiang Wang; Lu Wang; Ying Xiang; Daniel Ricklin; John D Lambris; Gang Chen
Journal:  Clin Immunol       Date:  2015-11-06       Impact factor: 3.969

Review 6.  Complement: structure, functions, evolution, and viral molecular mimicry.

Authors:  Dimitrios Mastellos; Dimitrios Morikis; Stuart N Isaacs; M Claire Holland; Cristoph W Strey; John D Lambris
Journal:  Immunol Res       Date:  2003       Impact factor: 4.505
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.